PCV65 PHARMACOECONOMIC ANALYSIS OF 160MG VALSARTAN VERSUS LOSARTAN AND TELMISARTAN IN THE TREATMENT OF SYSTEMIC ARTERIAL HYPERTENSION IN THE MEXICAN HEALTH SECTOR

Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67476-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)67476-1/fulltext
Title : PCV65 PHARMACOECONOMIC ANALYSIS OF 160MG VALSARTAN VERSUS LOSARTAN AND TELMISARTAN IN THE TREATMENT OF SYSTEMIC ARTERIAL HYPERTENSION IN THE MEXICAN HEALTH SECTOR
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67476-1&doi=10.1016/S1098-3015(10)67476-1
First page :
Section Title :
Open access? : No
Section Order : 41
Categories :
Tags :
Regions :
ViH Article Tags :